Thromb Haemost 2019; 119(08): 1365-1372
DOI: 10.1055/s-0039-1688828
Stroke, Systemic or Venous Thromboembolism
Georg Thieme Verlag KG Stuttgart · New York

Upper Extremity DVT versus Lower Extremity DVT: Perspectives from the GARFIELD-VTE Registry

Walter Ageno
1   Department of Medicine and Surgery, University of Insubria, Varese, Italy
,
Sylvia Haas
2   Department of Medicine, Technical University of Munich, Munich, Germany
,
Jeffrey I. Weitz
3   Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada
,
Samuel Z. Goldhaber
4   Harvard Medical School, Harvard University, Boston, Massachusetts, United States
,
Alexander G. G. Turpie
5   Department of Medicine, McMaster University, Hamilton, Ontario, Canada
,
Shinya Goto
6   Department of Medicine (Cardiology), Tokai University School of Medicine, Tokyo, Japan
,
Pantep Angchaisuksiri
7   Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
,
Joern Dalsgaard Nielsen
8   Copenhagen University Hospital, Copenhagen, Denmark
,
Gloria Kayani
9   Thrombosis Research Institute, London, United Kingdom
,
Alfredo E. Farjat
9   Thrombosis Research Institute, London, United Kingdom
,
Audrey Zaghdoun
9   Thrombosis Research Institute, London, United Kingdom
,
Sebastian Schellong
10   Medical Division 2, Municipal Hospital Dresden-Friedrichstadt, Dresden, Germany
,
Henri Bounameaux
11   Faculty of Medicine, University Hospitals of Geneva, Geneva, Switzerland
,
Lorenzo G. Mantovani
12   Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy
,
Paolo Prandoni
13   Arianna Foundation on Anticoagulation, Bologna, Italy
,
Harald Darius
14   Vivantes Neukoelln Medical Center, Berlin, Germany
,
Ajay K. Kakkar
15   Thrombosis Research Institute and University College London, London, United Kingdom
› Institutsangaben
Weitere Informationen

Publikationsverlauf

28. Januar 2019

29. März 2019

Publikationsdatum:
10. Juni 2019 (online)

Abstract

Upper extremity deep vein thrombosis (UEDVT) is less common than lower extremity DVT (LEDVT) and consequently less well characterized. This study compared clinical characteristics and 1-year outcomes between 438 UEDVT patients and 7,602 LEDVT patients recruited in the GARFIELD-VTE registry. UEDVT patients were significantly more likely to have a central venous catheter than those with LEDVT (11.5% vs. 0.5%; p < 0.0001), and had a higher rate of active cancer (16.2%) or recent hospitalization (19.4%) compared with LEDVT patients (8.7% and 11.2%, respectively). Nearly all patients with UEDVT and LEDVT were initiated on anticoagulant therapy, which was a direct oral anticoagulant in one-third individuals in both groups. At 3, 6, and 12 months, the proportion of UEDVT and LEDVT patients who were receiving anticoagulant therapy was 82.6 and 87.4%, 66.0 and 72.6%, and 45.7 and 54.6%, respectively. In the UEDVT and LEDVT groups, VTE recurrence rate was 4.0 (95% confidence interval [CI], 2.4–6.7) and 5.5 (95% CI, 4.9–6.1) per 100 person-years, respectively; major bleed was noted in 1.3 (95% CI, 0.6–3.2) and 1.6 (95% CI, 1.3–1.9) per 100 person-years and all-cause mortality in 9.7 (95% CI, 7.1–13.4) and 6.7 (95% CI, 6.1–7.3) per 100 person-years, respectively. Hence, risk of recurrence was similar in the two groups whereas all-cause mortality was significantly higher in the UEDVT group than the LEDVT group (p = 0.0338). This latter finding was likely due to the high prevalence of cancer in the UEDVT group.

Note

The GARFIELD-VTE Registry is an independent academic research initiative sponsored by the Thrombosis Research Institute (London, United Kingdom) and supported by an unrestricted research grant from Bayer Pharma AG (Berlin, Germany).


 
  • References

  • 1 Bernardi E, Pesavento R, Prandoni P. Upper extremity deep venous thrombosis. Semin Thromb Hemost 2006; 32 (07) 729-736
  • 2 Flinterman LE, Van Der Meer FJM, Rosendaal FR, Doggen CJM. Current perspective of venous thrombosis in the upper extremity. J Thromb Haemost 2008; 6 (08) 1262-1266
  • 3 Lechner D, Wiener C, Weltermann A, Eischer L, Eichinger S, Kyrle PA. Comparison between idiopathic deep vein thrombosis of the upper and lower extremity regarding risk factors and recurrence. J Thromb Haemost 2008; 6 (08) 1269-1274
  • 4 Muñoz FJ, Mismetti P, Poggio R. , et al; RIETE Investigators. Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE Registry. Chest 2008; 133 (01) 143-148
  • 5 Isma N, Svensson PJ, Gottsäter A, Lindblad B. Upper extremity deep venous thrombosis in the population-based Malmö thrombophilia study (MATS). Epidemiology, risk factors, recurrence risk, and mortality. Thromb Res 2010; 125 (06) e335-e338
  • 6 Spiezia L, Simioni P. Upper extremity deep vein thrombosis. Intern Emerg Med 2010; 5 (02) 103-109
  • 7 Bleker SM, van Es N, Kleinjan A. , et al. Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis. J Thromb Haemost 2016; 14 (05) 973-981
  • 8 Montiel FS, Ghazvinian R, Gottsäter A, Elf J. Treatment with direct oral anticoagulants in patients with upper extremity deep vein thrombosis. Thromb J 2017; 15: 26
  • 9 Cote LP, Greenberg S, Caprini JA. , et al; RIETE Investigators. Comparisons between upper and lower extremity deep vein thrombosis: a review of the RIETE Registry. Clin Appl Thromb Hemost 2017; 23 (07) 748-754
  • 10 Feinberg J, Nielsen EE, Jakobsen JC. Thrombolysis for acute upper extremity deep vein thrombosis. Cochrane Database Syst Rev 2017; 12: CD012175
  • 11 Vik A, Holme PA, Singh K. , et al. Catheter-directed thrombolysis for treatment of deep venous thrombosis in the upper extremities. Cardiovasc Intervent Radiol 2009; 32 (05) 980-987
  • 12 Lobo BL, Vaidean G, Broyles J, Reaves AB, Shorr RI. Risk of venous thromboembolism in hospitalized patients with peripherally inserted central catheters. J Hosp Med 2009; 4 (07) 417-422
  • 13 Marshall PS, Cain H. Upper extremity deep vein thrombosis. Clin Chest Med 2010; 31 (04) 783-797
  • 14 Malinoski DJ, Ewing T, Patel MS. , et al. The natural history of upper extremity deep venous thromboses in critically ill surgical and trauma patients: what is the role of anticoagulation?. J Trauma 2011; 71 (02) 316-321
  • 15 Lee JA, Zierler BK, Zierler RE. The risk factors and clinical outcomes of upper extremity deep vein thrombosis. Vasc Endovascular Surg 2012; 46 (02) 139-144
  • 16 Winters JP, Callas PW, Cushman M, Repp AB, Zakai NA. Central venous catheters and upper extremity deep vein thrombosis in medical inpatients: the Medical Inpatients and Thrombosis (MITH) Study. J Thromb Haemost 2015; 13 (12) 2155-2160
  • 17 Greene MT, Flanders SA, Woller SC, Bernstein SJ, Chopra V. The association between PICC use and venous thromboembolism in upper and lower extremities. Am J Med 2015; 128 (09) 986-993
  • 18 Spencer FA, Emery C, Lessard D, Goldberg RJ. ; Worcester Venous Thromboembolism Study. Upper extremity deep vein thrombosis: a community-based perspective. Am J Med 2007; 120 (08) 678-684
  • 19 Flinterman LE, van Hylckama Vlieg A, Rosendaal FR, Doggen CJM. Recurrent thrombosis and survival after a first venous thrombosis of the upper extremity. Circulation 2008; 118 (13) 1366-1372
  • 20 Klitfod L, Broholm R, Baekgaard N. Deep venous thrombosis of the upper extremity. A review. Int Angiol 2013; 32 (05) 447-452
  • 21 Arnhjort T, Persson LM, Rosfors S, Ludwigs U, Lärfars G. Primary deep vein thrombosis in the upper limb: a retrospective study with emphasis on pathogenesis and late sequelae. Eur J Intern Med 2007; 18 (04) 304-308
  • 22 Levy MM, Bach C, Fisher-Snowden R, Pfeifer JD. Upper extremity deep venous thrombosis: reassessing the risk for subsequent pulmonary embolism. Ann Vasc Surg 2011; 25 (04) 442-447
  • 23 Tadlock MD, Chouliaras K, Kennedy M. , et al. The origin of fatal pulmonary emboli: a postmortem analysis of 500 deaths from pulmonary embolism in trauma, surgical, and medical patients. Am J Surg 2015; 209 (06) 959-968
  • 24 Newton DH, Monreal Bosch M, Amendola M. , et al; RIETE Investigators. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry. J Vasc Surg Venous Lymphat Disord 2017; 5 (01) 18-24.e1
  • 25 Spirk D, Aujesky D, Stuck AK. , et al. Clinical outcomes of venous thromboembolism in patients with and without cancer: the SWIss Venous ThromboEmbolism Register (SWIVTER). Semin Thromb Hemost 2016; 42 (06) 642-649
  • 26 Mai C, Hunt D. Upper-extremity deep venous thrombosis: a review. Am J Med 2011; 124 (05) 402-407
  • 27 Kearon C, Akl EA, Comerota AJ. , et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis. 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl): e419S-e494S
  • 28 Kearon C, Akl EA, Ornelas J. , et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 2016; 149 (02) 315-352
  • 29 Weitz JI, Haas S, Ageno W. , et al. Global Anticoagulant Registry in the Field - Venous Thromboembolism (GARFIELD-VTE). Rationale and design. Thromb Haemost 2016; 116 (06) 1172-1179
  • 30 Schulman S, Kearon C. ; Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 3 (04) 692-694
  • 31 Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94 (446) 496-509
  • 32 Kleinjan A, Di Nisio M, Beyer-Westendorf J. , et al. Safety and feasibility of a diagnostic algorithm combining clinical probability, d-dimer testing, and ultrasonography for suspected upper extremity deep venous thrombosis: a prospective management study. Ann Intern Med 2014; 160 (07) 451-457
  • 33 Di Nisio M, Van Sluis GL, Bossuyt PM, Büller HR, Porreca E, Rutjes AW. Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review. J Thromb Haemost 2010; 8 (04) 684-692
  • 34 Czihal M, Hoffmann U. Upper extremity deep venous thrombosis. Vasc Med 2011; 16 (03) 191-202
  • 35 Ouriel K, Green RM, Greenberg RK, Clair DG. The anatomy of deep venous thrombosis of the lower extremity. J Vasc Surg 2000; 31 (05) 895-900
  • 36 Thijs W, Rabe KF, Rosendaal FR, Middeldorp S. Predominance of left-sided deep vein thrombosis and body weight. J Thromb Haemost 2010; 8 (09) 2083-2084
  • 37 Lyman GH, Khorana AA, Kuderer NM. , et al; American Society of Clinical Oncology Clinical Practice. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013; 31 (17) 2189-2204
  • 38 Jones MA, Lee DY, Segall JA. , et al. Characterizing resolution of catheter-associated upper extremity deep venous thrombosis. J Vasc Surg 2010; 51 (01) 108-113
  • 39 Decousus H, Bourmaud A, Fournel P. , et al; ONCOCIP Investigators. Cancer-associated thrombosis in patients with implanted ports: a prospective multicenter French cohort study (ONCOCIP). Blood 2018; 132 (07) 707-716
  • 40 Rathbun SW, Stoner JA, Whitsett TL. Treatment of upper-extremity deep vein thrombosis. J Thromb Haemost 2011; 9 (10) 1924-1930